What is LOPJLB’s current signal on ADCT?

LOPJLB’s latest quantitative signal on ADC Therapeutics S.A. (ADCT) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is ADCT in?

ADC Therapeutics S.A. (ADCT) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does ADC Therapeutics S.A. (ADCT) do?

ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its flagship product, ZYNLONTA, is presently being evaluated in multiple clinical trials: a Phase II study for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; a Ph…

Where is ADC Therapeutics S.A. based / listed?

ADC Therapeutics S.A. is based in CH, listed on NYSE.

ADC Therapeutics S.A. (ADCT)

COMPARE

Healthcare · Biotechnology · NYSE · CH

$1.59+11.97%Close

BUYRECOVERY · day 3

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $202M
Beta: 1.86
P/E (TTM): -1.92

Short % float: 5.54%
Days to cover: 3.9
SI change: -14.2%

1W: +47.22%
1M: +30.33%

vs SPY 1W: +45.66%
vs SPY 1M: +28.56%

Industry peers

FMP comparable companies · ranked by market cap

RAPTRAPT Therapeutics, Inc.$1.6B$58.01
OMERBUYOmeros Corporation$1.4BRECOVERYQ 17$19.12+1.97%
ALMSSELLAlumis Inc.$860MCRISISQ 1$6.97+2.95%
LXRXSELLLexicon Pharmaceuticals, Inc.$782MCRISISQ 5$1.76+0.00%
FDMTSELL4D Molecular Therapeutics, Inc.$664MCRISISQ 4$12.70+0.87%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news